Health & Environmental Research Online (HERO)


Print Feedback Export to File
9956482 
Journal Article 
Elevated levels of perfluoroalkyl substances in breast cancer patients within the Greater Manila Area 
Velarde, MC; Chan, AFO; Sajo, MEJV; Zakharevich, I; Melamed, J; Uy, GLB; Teves, JMY; Corachea, AJM; Valparaiso, AP; Macalindong, SS; Cabaluna, ND; Dofitas, RB; Giudice, LC; Gerona, RR 
2022 
Yes 
Chemosphere
ISSN: 0045-6535
EISSN: 1879-1298 
286 Pt 1 
Pt 1 
131545 
English 
is supplemented by 11316399 Supplemental:
Several studies have reported exposure of humans to various endocrine disrupting chemicals (EDCs) worldwide. However, there is a lack of data regarding EDC exposures in humans living in Southeast Asian countries, such as the Philippines. Hence, this study measured levels of 41 EDCs in women residing in the Greater Manila Area, home to the second largest city in Southeast Asia. Urine samples from women with versus without breast cancer were analyzed for 11 phthalate metabolites, 8 environmental phenols, and 10 bisphenols, while serum samples were analyzed for 12 perfluoroalkyl substances (PFAS). Out of the four groups of EDCs analyzed, PFAS were significantly associated with breast cancer (adjusted OR = 13.63, 95% CI: 3.24-94.88 p-trend = 0.001 for PFDoA; adjusted OR = 9.26, 95% CI 2.54-45.10, p-trend = 0.002 for PFDA; and adjusted OR = 2.66, 95% CI: 0.95-7.66, p-trend = 0.004 for PFHxA). Long-chain PFAS levels were positively correlated with age and were significantly higher in women from Region IV-A, a heavily industrialized region, than from the National Capital Region. Overall, this study showed baseline information regarding the level of EDCs in Filipinas, providing a glimpse of EDC exposure in women living in a megalopolis city in Southeast Asia. 
EDC; endocrine disruptor; mammary cancer; Philippines; PFAS; Southeast Asia 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search Update December 2021
          PubMed
     Screened Studies
          Included
               Include (TIAB)
               Include (Full Text)
     Not prioritized for screening
     9-chlorohexadecafluoro-3-oxanonane-1-sulfonic acid
     Perfluorododecanoic acid
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch Update- December 2022
          Pubmed
          Web of Science
     Screened Studies
          Included
               Include (TIAB)
          Excluded
               Exclude (Full Text)
     Perfluorododecanoic acid
• PFAS 150
     Missing 2021 searches
     Screened Studies
          Included
               Include (TIAB)
               Include (Full Text)
• PFAS Universe
     Data Source
          Web of Science
          Pubmed
          Screened Studies
               Included
                    Include (TIAB)
                    Include (Full Text)
     Perfluorodecanoate
     Perfluorodecanoic acid
     Perfluorododecanoic acid
     Perfluorohexanoate
     Perfluorohexanoic acid
• PFDA
     Literature Search
          Pubmed
          WOS
     Literature Search Update 4/2022
          PubMed
          WoS
     Literature Searches (through April 2023 update and post-public comment/peer review)
          Title & Abstract Screening
               Full Text Screening
                    Studies Meeting PECO
                         Human health effects studies
• PFHxA
     LitSearch Update: April 2021 - April 2022
          PubMed
          WOS
     HAWC
• PFHxS
     Database searches
          Other
     Inclusion
          Full Text
               Human Study
     Supplemental
          Other assessments or records with no original data (e.g., reviews etc)
• PFNA
     Title and Abstract Screening
          Full Text Screening
               Studies Meeting PECO
                    Human health effects studies